Scarabelli Guido, Provasi Davide, Negri Ana, Filizola Marta
Department of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, New York, NY.
Biopolymers. 2014 Jan;101(1):21-7. doi: 10.1002/bip.22251.
Delta-opioid (DOP) receptors are members of the G protein-coupled receptor (GPCR) sub-family of opioid receptors, and are evolutionarily related, with homology exceeding 70%, to cognate mu-opioid (MOP), kappa-opioid (KOP), and nociceptin opioid (NOP) receptors. DOP receptors are considered attractive drug targets for pain management because agonists at these receptors are reported to exhibit strong antinociceptive activity with relatively few side effects. Among the most potent analgesics targeting the DOP receptor are the linear and cyclic enkephalin analogs known as DADLE (Tyr-D-Ala-Gly-Phe-D-Leu) and DPDPE (Tyr-D-Pen-Gly-Phe-D-Pen), respectively. Several computational and experimental studies have been carried out over the years to characterize the conformational profile of these penta-peptides with the ultimate goal of designing potent peptidomimetic agonists for the DOP receptor. The computational studies published to date, however, have investigated only a limited range of timescales and used over-simplified representations of the solvent environment. We provide here a thorough exploration of the conformational space of DADLE and DPDPE in an explicit solvent, using microsecond-scale molecular dynamics and bias-exchange metadynamics simulations. Free-energy profiles derived from these simulations point to a small number of DADLE and DPDPE conformational minima in solution, which are separated by relatively small energy barriers. Candidate bioactive forms of these peptides are selected from identified common spatial arrangements of key pharmacophoric points within all sampled conformations.
δ-阿片受体(DOP)是阿片受体G蛋白偶联受体(GPCR)亚家族的成员,在进化上与同源的μ-阿片受体(MOP)、κ-阿片受体(KOP)和孤啡肽阿片受体(NOP)相关,同源性超过70%。DOP受体被认为是疼痛管理中有吸引力的药物靶点,因为据报道这些受体的激动剂具有强大的抗伤害感受活性且副作用相对较少。靶向DOP受体的最有效的镇痛药分别是线性和环状脑啡肽类似物,即DADLE(酪氨酸-D-丙氨酸-甘氨酸-苯丙氨酸-D-亮氨酸)和DPDPE(酪氨酸-D-青霉胺-甘氨酸-苯丙氨酸-D-青霉胺)。多年来已经进行了多项计算和实验研究来表征这些五肽的构象特征,最终目标是设计出针对DOP受体的强效拟肽激动剂。然而,迄今为止发表的计算研究仅考察了有限的时间尺度,并且使用了过于简化 的溶剂环境表示。我们在此使用微秒级分子动力学和偏置交换元动力学模拟,对DADLE和DPDPE在显式溶剂中的构象空间进行了全面探索。从这些模拟得出的自由能分布图表明,溶液中DADLE和DPDPE的构象最小值数量较少,它们之间被相对较小的能垒隔开。这些肽的候选生物活性形式是从所有采样构象中关键药效基团点的已确定的常见空间排列中选择的。